全文获取类型
收费全文 | 689篇 |
免费 | 38篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 8篇 |
妇产科学 | 44篇 |
基础医学 | 92篇 |
口腔科学 | 18篇 |
临床医学 | 64篇 |
内科学 | 132篇 |
皮肤病学 | 21篇 |
神经病学 | 28篇 |
特种医学 | 17篇 |
外科学 | 89篇 |
综合类 | 42篇 |
一般理论 | 1篇 |
预防医学 | 41篇 |
眼科学 | 12篇 |
药学 | 86篇 |
中国医学 | 8篇 |
肿瘤学 | 27篇 |
出版年
2024年 | 1篇 |
2023年 | 12篇 |
2022年 | 22篇 |
2021年 | 38篇 |
2020年 | 26篇 |
2019年 | 25篇 |
2018年 | 35篇 |
2017年 | 15篇 |
2016年 | 26篇 |
2015年 | 18篇 |
2014年 | 37篇 |
2013年 | 42篇 |
2012年 | 55篇 |
2011年 | 66篇 |
2010年 | 20篇 |
2009年 | 24篇 |
2008年 | 36篇 |
2007年 | 54篇 |
2006年 | 30篇 |
2005年 | 37篇 |
2004年 | 23篇 |
2003年 | 15篇 |
2002年 | 15篇 |
2001年 | 6篇 |
2000年 | 5篇 |
1999年 | 7篇 |
1998年 | 4篇 |
1997年 | 6篇 |
1996年 | 3篇 |
1995年 | 2篇 |
1994年 | 1篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 3篇 |
1985年 | 1篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 2篇 |
1974年 | 1篇 |
1973年 | 6篇 |
1972年 | 1篇 |
排序方式: 共有732条查询结果,搜索用时 15 毫秒
81.
Kuesters S Grueneberger JM Baumann T Bukhari W Daoud M Hopt UT Karcz WK 《Surgical endoscopy》2012,26(6):1718-1723
Background
A growing number of revisionary and secondary bariatric operations have been performed in recent years, with the number of operations doubling each year at the authors’ center. Diagnostics, indications, and most revisionary operations should be performed by an experienced bariatric surgeon. This study was undertaken to evaluate indications and outcomes of revisionary bariatric operations at a specialized center.Methods
At the Centre of Obesity and Metabolic Surgery (University of Freiburg, Germany), 100 consecutive revisionary bariatric operations performed between March 2007 and September 2009 were analyzed concerning indications and outcomes.Results
Only 9 of the 100 revisions were due to early complications (<30?days after the primary operation). The indication for most revisions was poor weight loss (n?=?55). A mean body mass index reduction of 10 points could be achieved in 1?year, which equals a 56% excess weight loss (EWL). No significant difference in weight reduction between restrictive and malabsorptive revisions was observed. Revisions due to implant-related problems also were frequent (n?=?25). Laparoscopic revision was possible in 95% of the cases.Conclusion
Insufficient weight loss is the most frequent indication for revisionary bariatric surgery. The surgery can be performed laparoscopically in most cases, and a significant EWL (>?50%) can be achieved in 1?year if the right revisionary procedure is chosen. 相似文献82.
Lubna Khatoon Frederick N. Baliraine Salman A. Malik Guiyun Yan 《The Brazilian journal of infectious diseases》2013,17(5):596-600
Plasmodium vivax and Plasmodium falciparum are becoming resistant to drugs including antifolates, sulphonamides and chloroquine. This study was focused at sequence analysis of resistant genes of these parasites against sulphadoxine–pyrimethamine and chloroquine, from Bannu, Pakistan. Known mutations were detected at codons 57, 58 and 117 of pvdhfr gene of P. vivax, while none of the isolates had any pvdhps mutation. Similarly P. falciparum isolates exhibited double 59R + 108N mutations in pfdhfr, and single 437G in pfdhps thus demonstrating the existance of triple mutant 59R + 108N + 437G haplotype in this region. The key chloroquine resistance mutation, 76T in pfcrt was observed in 100% of the P. falciparum isolates, with haplotype SVMNT which is also associated with resistance to amodiaquine. Some novel mutations were also observed in pvdhfr and pfdhfr genes. 相似文献
83.
Judith M. Gottwein Sanne B. Jensen Yi-Ping Li Lubna Ghanem Troels K. H. Scheel Stéphanie B. N. Serre Lotte Mikkelsen Jens Bukh 《Antimicrobial agents and chemotherapy》2013,57(3):1291-1303
With the development of directly acting antivirals, hepatitis C virus (HCV) therapy entered a new era. However, rapid selection of resistance mutations necessitates combination therapy. To study combination therapy in infectious culture systems, we aimed at developing HCV semi-full-length (semi-FL) recombinants relying only on the JFH1 NS3 helicase, NS5B, and the 3′ untranslated region. With identified adaptive mutations, semi-FL recombinants of genotypes(isolates) 1a(TN) and 3a(S52) produced supernatant infectivity titers of ∼4 log10 focus-forming units/ml in Huh7.5 cells. Genotype 1a(TN) adaptive mutations allowed generation of 1a(H77) semi-FL virus. Concentration-response profiles revealed the higher efficacy of the NS3 protease inhibitor asunaprevir (BMS-650032) and the NS5A inhibitor daclatasvir (BMS-790052) against 1a(TN and H77) than 3a(S52) viruses. Asunaprevir had intermediate efficacy against previously developed 2a recombinants J6/JFH1 and J6cc. Daclatasvir had intermediate efficacy against J6/JFH1, while low sensitivity was confirmed against J6cc. Using a cross-titration scheme, infected cultures were treated until viral escape or on-treatment virologic suppression occurred. Compared to single-drug treatment, combination treatment with relatively low concentrations of asunaprevir and daclatasvir suppressed infection with all five recombinants. Escaped viruses primarily had substitutions at amino acids in the NS3 protease and NS5A domain I reported to be genotype 1 resistance mutations. Inhibitors showed synergism at drug concentrations reported in vivo. In summary, semi-FL HCV recombinants, including the most advanced reported genotype 3a infectious culture system, permitted genotype-specific analysis of combination treatment in the context of the complete viral life cycle. Despite differential sensitivity to lead compound NS3 protease and NS5A inhibitors, genotype 1a, 2a, and 3a viruses were suppressed by combination treatment with relatively low concentrations. 相似文献
84.
Judith M. Gottwein Sanne B. Jensen Stéphanie B. N. Serre Lubna Ghanem Troels K. H. Scheel Tanja B. Jensen Henrik Krarup Nathalie Uzcategui Lotte S. Mikkelsen Jens Bukh 《Antimicrobial agents and chemotherapy》2013,57(12):6034-6049
To facilitate studies of hepatitis C virus (HCV) NS4A, we aimed at developing J6/JFH1-based recombinants with genotype 1- to 7-specific NS4A proteins. We developed efficient culture systems expressing NS4A proteins of genotypes (isolates) 1a (H77 and TN), 1b (J4), 2a (J6), 4a (ED43), 5a (SA13), 6a (HK6a), and 7a (QC69), with peak infectivity titers of ∼3.5 to 4.5 log10 focus-forming units per ml. Except for genotype 2a (J6), growth depended on adaptive mutations identified in long-term culture. Genotype 1a, 1b, and 4a recombinants were adapted by amino acid substitutions F772S (p7) and V1663A (NS4A), while 5a, 6a, and 7a recombinants required additional substitutions in the NS3 protease and/or NS4A. We demonstrated applicability of the developed recombinants for study of antivirals. Genotype 1 to 7 NS4A recombinants showed similar responses to the protease inhibitors telaprevir (VX-950), boceprevir (Sch503034), simeprevir (TMC435350), danoprevir (ITMN-191), and vaniprevir (MK-7009), to alpha interferon 2b, and to the putative NS4A inhibitor ACH-806. The efficacy of ACH-806 was lower than that of protease inhibitors and was not influenced by changes at amino acids 1042 and 1065 (in the NS3 protease), which have been suggested to mediate resistance to ACH-806 in replicons. Genotype 1a, 1b, and 2a recombinants showed viral spread under long-term treatment with ACH-806, without acquisition of resistance mutations in the NS3-NS4A region. Relatively high concentrations of ACH-806 inhibited viral assembly, but not replication, in a single-cycle production assay. The developed HCV culture systems will facilitate studies benefitting from expression of genotype-specific NS4A in a constant backbone in the context of the complete viral replication cycle, including functional studies and evaluations of the efficacy of antivirals. 相似文献
85.
86.
Haddad H. Alkaff Bayan O. Besharah Deemah H. Bukhari Suhail I. Sayed Mohammad A. Alessa Sherif K. Abdelmonim Saeed A. Alghamdi Fares E. Alghamdi Omar A. Abu Suliman Firas R. Abi Sheffah Anas H. Al-Tammas Rajab A. Al-Zahrani Osama A. Marglani John C. Heaphy Osama A. Bawazir Ameen Z. Alherabi 《Saudi medical journal》2020,41(12):1330
87.
88.
89.
90.